Elevance Health Inc. (0HG8.L)
USD 371.42
(0.32%)
USD 371.42
(0.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 108.92 Billion USD | 5.99% |
| 2022 | 102.77 Billion USD | 5.62% |
| 2021 | 97.3 Billion USD | 12.34% |
| 2020 | 86.61 Billion USD | 11.83% |
| 2019 | 77.45 Billion USD | 8.22% |
| 2018 | 71.57 Billion USD | 1.46% |
| 2017 | 70.54 Billion USD | 8.38% |
| 2016 | 65.08 Billion USD | 5.45% |
| 2015 | 61.71 Billion USD | -0.56% |
| 2014 | 62.06 Billion USD | 4.18% |
| 2013 | 59.57 Billion USD | 1.05% |
| 2012 | 58.95 Billion USD | 13.33% |
| 2011 | 52.01 Billion USD | 3.69% |
| 2010 | 50.16 Billion USD | -3.76% |
| 2009 | 52.12 Billion USD | 7.69% |
| 2008 | 48.4 Billion USD | -7.02% |
| 2007 | 52.06 Billion USD | 0.58% |
| 2006 | 51.75 Billion USD | 0.69% |
| 2005 | 51.4 Billion USD | 29.36% |
| 2004 | 39.73 Billion USD | 195.7% |
| 2003 | 13.43 Billion USD | 9.32% |
| 2002 | 12.29 Billion USD | 95.86% |
| 2001 | 6.27 Billion USD | 9.95% |
| 2000 | 5.7 Billion USD | 18.53% |
| 1999 | 4.81 Billion USD | 10.48% |
| 1998 | 4.35 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 116.53 Billion USD | 3.14% |
| 2024 Q1 | 111.89 Billion USD | 2.72% |
| 2024 Q2 | 112.98 Billion USD | 0.98% |
| 2023 FY | 108.92 Billion USD | 5.99% |
| 2023 Q3 | 110.47 Billion USD | 1.2% |
| 2023 Q4 | 108.92 Billion USD | -1.4% |
| 2023 Q1 | 109.04 Billion USD | 6.1% |
| 2023 Q2 | 109.16 Billion USD | 0.12% |
| 2022 Q2 | 100.87 Billion USD | 0.39% |
| 2022 Q4 | 102.77 Billion USD | -0.25% |
| 2022 FY | 102.77 Billion USD | 5.62% |
| 2022 Q1 | 100.48 Billion USD | 3.27% |
| 2022 Q3 | 103.02 Billion USD | 2.13% |
| 2021 Q2 | 96.09 Billion USD | 0.43% |
| 2021 FY | 97.3 Billion USD | 12.34% |
| 2021 Q3 | 98.06 Billion USD | 2.04% |
| 2021 Q4 | 97.3 Billion USD | -0.77% |
| 2021 Q1 | 95.68 Billion USD | 10.47% |
| 2020 Q1 | 82.39 Billion USD | 6.39% |
| 2020 FY | 86.61 Billion USD | 11.83% |
| 2020 Q4 | 86.61 Billion USD | 0.05% |
| 2020 Q3 | 86.57 Billion USD | -1.59% |
| 2020 Q2 | 87.97 Billion USD | 6.77% |
| 2019 FY | 77.45 Billion USD | 8.22% |
| 2019 Q3 | 77.8 Billion USD | 2.58% |
| 2019 Q4 | 77.45 Billion USD | -0.46% |
| 2019 Q1 | 74.52 Billion USD | 4.12% |
| 2019 Q2 | 75.85 Billion USD | 1.78% |
| 2018 Q3 | 74.44 Billion USD | 0.1% |
| 2018 FY | 71.57 Billion USD | 1.46% |
| 2018 Q2 | 74.36 Billion USD | 1.46% |
| 2018 Q4 | 71.57 Billion USD | -3.86% |
| 2018 Q1 | 73.3 Billion USD | 3.91% |
| 2017 Q2 | 68.23 Billion USD | -1.02% |
| 2017 FY | 70.54 Billion USD | 8.38% |
| 2017 Q4 | 70.54 Billion USD | 3.26% |
| 2017 Q3 | 68.3 Billion USD | 0.11% |
| 2017 Q1 | 68.94 Billion USD | 5.93% |
| 2016 Q3 | 64.39 Billion USD | 0.53% |
| 2016 FY | 65.08 Billion USD | 5.45% |
| 2016 Q2 | 64.06 Billion USD | 0.32% |
| 2016 Q1 | 63.85 Billion USD | 3.47% |
| 2016 Q4 | 65.08 Billion USD | 1.06% |
| 2015 Q1 | 65.54 Billion USD | 5.61% |
| 2015 Q2 | 64.26 Billion USD | -1.96% |
| 2015 Q3 | 62.33 Billion USD | -3.0% |
| 2015 Q4 | 61.71 Billion USD | -0.99% |
| 2015 FY | 61.71 Billion USD | -0.56% |
| 2014 Q4 | 62.06 Billion USD | 0.01% |
| 2014 Q3 | 62.05 Billion USD | -0.39% |
| 2014 Q1 | 61.68 Billion USD | 3.54% |
| 2014 Q2 | 62.3 Billion USD | 1.0% |
| 2014 FY | 62.06 Billion USD | 4.18% |
| 2013 Q4 | 59.57 Billion USD | -1.14% |
| 2013 FY | 59.57 Billion USD | 1.05% |
| 2013 Q2 | 59.61 Billion USD | 0.34% |
| 2013 Q1 | 59.4 Billion USD | 0.77% |
| 2013 Q3 | 60.26 Billion USD | 1.09% |
| 2012 Q3 | 55.81 Billion USD | 2.35% |
| 2012 Q1 | 52.49 Billion USD | 0.92% |
| 2012 Q4 | 58.95 Billion USD | 5.62% |
| 2012 FY | 58.95 Billion USD | 13.33% |
| 2012 Q2 | 54.53 Billion USD | 3.88% |
| 2011 FY | 52.01 Billion USD | 3.69% |
| 2011 Q4 | 52.01 Billion USD | -1.01% |
| 2011 Q1 | 50.91 Billion USD | 1.5% |
| 2011 Q2 | 50.87 Billion USD | -0.08% |
| 2011 Q3 | 52.54 Billion USD | 3.29% |
| 2010 Q1 | 51.18 Billion USD | -1.81% |
| 2010 FY | 50.16 Billion USD | -3.76% |
| 2010 Q2 | 50.16 Billion USD | -1.99% |
| 2010 Q4 | 50.16 Billion USD | -1.7% |
| 2010 Q3 | 51.03 Billion USD | 1.74% |
| 2009 Q2 | 49.34 Billion USD | -0.14% |
| 2009 Q3 | 49.49 Billion USD | 0.31% |
| 2009 Q4 | 52.12 Billion USD | 5.31% |
| 2009 FY | 52.12 Billion USD | 7.69% |
| 2009 Q1 | 49.41 Billion USD | 2.09% |
| 2008 Q4 | 48.4 Billion USD | -2.72% |
| 2008 Q1 | 51.55 Billion USD | -0.97% |
| 2008 Q2 | 50.97 Billion USD | -1.12% |
| 2008 FY | 48.4 Billion USD | -7.02% |
| 2008 Q3 | 49.75 Billion USD | -2.39% |
| 2007 Q3 | 52.89 Billion USD | -2.39% |
| 2007 Q4 | 52.06 Billion USD | -1.59% |
| 2007 FY | 52.06 Billion USD | 0.58% |
| 2007 Q2 | 54.19 Billion USD | 1.32% |
| 2007 Q1 | 53.48 Billion USD | 3.34% |
| 2006 Q3 | 51.48 Billion USD | 2.78% |
| 2006 FY | 51.75 Billion USD | 0.69% |
| 2006 Q4 | 51.75 Billion USD | 0.54% |
| 2006 Q2 | 50.09 Billion USD | -2.48% |
| 2006 Q1 | 51.36 Billion USD | -0.08% |
| 2005 Q1 | 40.48 Billion USD | 1.89% |
| 2005 Q2 | 41.69 Billion USD | 2.97% |
| 2005 Q3 | 41.85 Billion USD | 0.39% |
| 2005 FY | 51.4 Billion USD | 29.36% |
| 2005 Q4 | 51.4 Billion USD | 22.82% |
| 2004 Q4 | 39.73 Billion USD | 181.1% |
| 2004 Q3 | 14.13 Billion USD | 3.5% |
| 2004 Q2 | 13.65 Billion USD | -1.95% |
| 2004 FY | 39.73 Billion USD | 195.7% |
| 2004 Q1 | 13.92 Billion USD | 3.66% |
| 2003 Q2 | 12.9 Billion USD | 3.21% |
| 2003 Q3 | 13.2 Billion USD | 2.3% |
| 2003 Q4 | 13.43 Billion USD | 1.77% |
| 2003 FY | 13.43 Billion USD | 9.32% |
| 2003 Q1 | 12.5 Billion USD | 1.74% |
| 2002 Q3 | 12.23 Billion USD | 84.23% |
| 2002 FY | 12.29 Billion USD | 95.86% |
| 2002 Q4 | 12.29 Billion USD | 0.47% |
| 2002 Q1 | 6.4 Billion USD | 2.01% |
| 2002 Q2 | 6.64 Billion USD | 3.72% |
| 2001 FY | 6.27 Billion USD | 9.95% |
| 2001 Q4 | 6.27 Billion USD | 3.01% |
| 2001 Q3 | 6.09 Billion USD | 0.0% |
| 2000 FY | 5.7 Billion USD | 18.53% |
| 1999 FY | 4.81 Billion USD | 10.48% |
| 1998 FY | 4.35 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -29253.922% |
| Accuray Incorporated | 468.62 Million USD | -23144.073% |
| Align Technology, Inc. | 6.08 Billion USD | -1690.437% |
| AxoGen, Inc. | 196.82 Million USD | -55242.001% |
| Boston Scientific Corporation | 35.13 Billion USD | -210.018% |
| CVS Health Corporation | 249.72 Billion USD | 56.381% |
| Cardinal Health, Inc. | 45.12 Billion USD | -141.413% |
| Centene Corporation | 84.64 Billion USD | -28.694% |
| DaVita Inc. | 17.61 Billion USD | -518.225% |
| HCA Healthcare, Inc. | 56.21 Billion USD | -93.784% |
| Hologic, Inc. | 9.15 Billion USD | -1089.69% |
| Humana Inc. | 47.06 Billion USD | -131.442% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -3241.427% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -551.285% |
| Masimo Corporation | 3.04 Billion USD | -3481.391% |
| McKesson Corporation | 67.44 Billion USD | -61.511% |
| Patterson Companies, Inc. | 2.96 Billion USD | -3568.768% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -676.836% |
| ResMed Inc. | 6.87 Billion USD | -1485.008% |
| Henry Schein, Inc. | 10.57 Billion USD | -930.247% |
| Teladoc Health, Inc. | 4.39 Billion USD | -2379.937% |
| Universal Health Services, Inc. | 14.35 Billion USD | -658.718% |
| Veeva Systems Inc. | 5.91 Billion USD | -1742.826% |
| Baxter International Inc. | 28.27 Billion USD | -285.231% |
| Becton, Dickinson and Company | 52.78 Billion USD | -106.381% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -605.424% |
| Danaher Corporation | 84.48 Billion USD | -28.927% |
| Stryker Corporation | 39.91 Billion USD | -172.92% |
| Medtronic plc | 89.98 Billion USD | -21.057% |